Sionna Therapeutics (SION) Profit After Tax (2024 - 2026)

Sionna Therapeutics has disclosed Profit After Tax across 3 years of filings, most recently posting -$26.8 million for Q1 2026.

• Profit After Tax for Q1 2026 came in at -$26.8 million, down 62.47% year-over-year; the trailing twelve-month figure through Mar 2026 was -$85.6 million (down 29.01% YoY), and the FY2025 annual result was -$75.3 million, down 22.01% from the prior year.
• Profit After Tax came in at -$26.8 million for Q1 2026 at Sionna Therapeutics, down from -$20.4 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$8.6 million in Q2 2024 to a low of -$26.8 million in Q1 2026.
• The 3-year median for Profit After Tax is -$18.1 million (2025), against an average of -$18.2 million.
• Peak annual rise in Profit After Tax reached 20.29% in 2025, while the deepest fall reached 111.27% in 2025.
• Sionna Therapeutics' Profit After Tax stood at -$15.8 million in 2024, then retreated by 28.98% to -$20.4 million in 2025, then plunged by 31.01% to -$26.8 million in 2026.
• The last three Profit After Tax figures came in at -$26.8 million (Q1 2026), -$20.4 million (Q4 2025), and -$20.3 million (Q3 2025), per Business Quant data.